A new proposal of an ultrasonic imaging model for predicting overall and progression-free survival in patients with primary hepatocellular carcinoma
    PDF
    Cite
    Share
    Request
    Abdominal Imaging - Original Article
    P: 301-311
    July 2022

    A new proposal of an ultrasonic imaging model for predicting overall and progression-free survival in patients with primary hepatocellular carcinoma

    Diagn Interv Radiol 2022;28(4):301-311
    1. Department of Ultrasound, Shangluo Central Hospital, Shaanxi; People’s Republic of China
    2. Department of Utrasound, Xianyang Maternal and Child Health Hospital, Shaanxi; People’s Republic of China
    No information available.
    No information available
    Received Date: 03.10.2020
    Accepted Date: 15.04.2021
    PDF
    Cite
    Share
    Request

    ABSTRACT

    PURPOSE

    We aimed to develop models for predicting overall survival (OS) and progression-free survival (PFS) of patients with primary hepatocellular carcinoma (HCC).

    METHODS

    Clinicopathological characteristics and laboratory information of patients were collected. We retrospectively analyzed presurgical data of 216 patients with primary HCC. The random forest and least absolute shrinkage and selection operator regression models were used to select features. We established prognostic models for predicting OS and PFS of primary liver cancer using ultrasonic imaging as well as clinical and pathological features. Accuracy of the models was evaluated using area under the curve, C index, and calibration curves, whereas their clinical application value was assessed using decision curve analysis.

    RESULTS

    Models for predicting OS and PFS were established based on ultrasonic imaging accessible features. The models showed excellent accuracy and prognosis prediction of OS and PFS in patients with primary HCC.

    CONCLUSION

    The established models based on factors such as aspartate aminotransferase platelet ratio index, Child-Turcotte-Pugh grade, tumor grade, hepatitis B virus-DNA, the intensity of ultrasound enhancement at the portal stage, lymphocyte/monocyte ratio, portal hypertension, gender, stage, the beginning time of ultrasonic contrast, and the total grade of ultrasonic enhancement can effectively predict OS and PFS of primary HCC.

    References

    2024 ©️ Galenos Publishing House